RBC Target 2027 Canadian Corporate Bond Index ETF (RGP) Quote

Thanks docsetc. At this point in my life, even if I loose all the investment it would be nice to reveal how corrupt the CCC mgmt is. Need to keep this thieves from continuing to steal money from investors. 

Suit yourself!! I'll leave the light on for ya!!

$CNRC .0361 must read »»
Appraised asset values of $2.60 per share - 2023 proforma earnings of $0.08 per share

#Oil #Gas #Crypto #Lithium #Gold #Copper #Colbalt #PreciousRareEarth

Market Cap $6,405,688 Super Low
355,871,532 Outstanding Shares
224,53

Why did this turn around today?  Passage of kidney bill increasing chance?

$RDAR ~Nice to see that after the OTC Markets was updated yesterday on RDAR's security details there was ZERO dilution this past week which means the toxic notes selling into the market have finally come to their end:

RDAR SECURITY DETAILS
Share Structure
Market Cap Mar

Lara Trump is the top choice to replace Marco Rubio as Florida senator: ‘She needs to make a decision’


https://www.msn.com/en-us/news/politics/lara-trump-is-the-top-choice-to-replace-marco-rubio-as-florida-senator-she-needs-to-make-a-decision/ar-AA1u1Fsu?ocid=BingNewsVerp

Ridin 594P .36! From Top 5 min Channel !

This synergistic combination of resources, along with Adnexus's cutting-edge Sutra AI Drug Discovery Platform, creates a powerful foundation for continued innovation and growth, ultimately delivering significant value for patients and shareholders alike.

Very fishy !!!

I AGREE with you that Vivos is NOT abandoning the pursuit of attaining the FDA's approval to begin US clinical trials.

I DISAGREE with the following: "I also want to know why working domestic and overseas wasn't always part of the plan."

The dual track plan to pursue o

CEO Jim Morrison shares what sets EvoBio apart: our partnership with an ISO 5 certified lab and the unique advantage of producing our own exosomes.

https://x.com/EvoBiologics/status/1857083766205817152?t=bOZ5Zr6BE2cPI0-7dUBhZg&s=19

Na, it's called.....know when to hold'em and when to fold!! Market is not buying the fluff reports!! I might buy in the low trips!!

Hardly, but I will put you down as a yes indeed with your projection, and any like you....

You should learn to speak out against your own side when they've gone too far......Putting kids behind ideology is a very,very bad look, the worst of all as a matter of fact...

Th

$ILLR Investors should be eating up the stock like it’s the hottest soup on the menu! 🍲 With strategic partnerships and explosive growth potential, @Triller is serving up opportunities you don't want to miss. 🥄💼 #ILLRInvestors #StockMarket @triller_IR

It is on legal paper now, but not much on mt vernon. 5000 tons ain't much in mining.

5 to 10k ounces

Won't get it for a week or two. Gold is a month out i would say.

If train gets borrowed by Santa to put around a Christmas tree, maybe after xmas.

$ILLR Investors should be eating up the stock like it’s the hottest soup on the menu! 🍲 With strategic partnerships and explosive growth potential, @Triller is serving up opportunities you don't want to miss. 🥄💼 #ILLRInvestors #StockMarket @triller_IR

You too brother

When the dregs of society become empowered, the choices they make do not change. Empathy, conscience, integrity, and responsibility are not ingredients of THAT soup. A sort of moron revolution like Chairman Mao inflicted on China.

Rory is the one who has been running the company and it’s mind boggling he gets no blame for wiping out shareholder value over the years, smh…

My Account looks like a dumpster fire

Doomed I say!!

For now

Waiting for my BIDs to fill for the next rip. Looking for the lower to mid $20's 🙏

The dips & rips this cash cow gives us keeps me coming back for more 💪🤑




$DJT

XTIA 10 day hourly

https://investorshub.advfn.com/uimage/uploads/2024/11/14/bpgihIMG_3297.gif

Austen Lambrecht, CEO of 1606 Corp., commented, "The merger between Adnexus Biotechnologies and Sanctum Therapeutics marks a pivotal moment in the fight against HIV and other infectious diseases. By combining Adnexus's cutting-edge AI-driven drug discovery platform with Sanctum's breakthrough therap

Oh, I agree the clothing line will need marketing. I just don't think KBLB will be doing it. And I'd be thankful if they didn't. Having the end customer/partner do that marketing, as I thought was agreed upon in their arrangement with Kings, to me, seems the wisest avenue.